Director/PDMR Shareholding

RNS Number : 6878G

Hikma Pharmaceuticals Plc

13 March 2024

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 13 March 2024: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 25 February 2022 under the 2014 Executive Incentive Plan ("EIP") Element B and 25 February 2021 under the EIP Element C.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 34,652
		Nil	EIP Award, Element C: 19,830
d)	Aggregated information	Price(s): nil Volume(s): 54,482
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Riad Mishlawi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Riad Mishlawi
2	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 22,099
		Nil	EIP Award, Element C: 17,120
d)	Aggregated information	Price(s): nil Volume(s): 39,219
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 26,812
		Nil	EIP Award, Element C: 13,903
d)	Aggregated information	Price(s): nil Volume(s): 40,715
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Khalid Nabilsi

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Khalid Nabilsi
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 20,643
		Nil	EIP Award, Element C: 13,927
d)	Aggregated information	Price(s): nil Volume(s): 34,570
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Brian Hoffmann

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian Hoffmann
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 14,663
		Nil	EIP Award, Element C: 10,227
d)	Aggregated information	Price(s): nil Volume(s): 24,890
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£18.942	EIP Award, Element B: 5,471
		£18.942	EIP Award, Element C: 3,816
d)	Aggregated information	Price(s): £18.942 Volume(s): 9,287 Total(s): £175,916.51
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Susan Ringdal

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Susan Ringdal
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 11,072
		Nil	EIP Award, Element C: 6,812
d)	Aggregated information	Price(s): nil Volume(s): 17,844
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares sold to cover tax following the vesting of conditional awards under the EIP Element B and EIP Element C.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£18.942	EIP Award, Element B: 5,109
		£18.942	EIP Award, Element C: 3,144
d)	Aggregated information	Price(s): £18.942 Volume(s): 8,253 Total(s): £156,330.24
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Hussein Arkhagha

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Hussein Arkhagha
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Shares acquired from the vesting of conditional awards under the EIP Element B and EIP Element C. All Shares were retained.
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		Nil	EIP Award, Element B: 10,598
		Nil	EIP Award, Element C: 5,245
d)	Aggregated information	Price(s): nil Volume(s): 15,843
e)	Date of the transaction	12 March 2024
f)	Place of the transaction	London Stock Exchange (XLON)

Helen Middlemist
Group Company Secretary

+44 (0)20 7399 2760

13 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGCGDXGSBDGSX

TIDM	HIK
Share Price	1,615.00p-0.80%
Market Cap	£3.37bn

Date	13 Mar 2024
Time	09:42:13
Category	Director/PDMR dealings
ID	6878G

TIDM	HIK
Share Price	1,615.00p-0.80%
Market Cap	£3.37bn

Date	13 Mar 2024
Time	09:42:13
Category	Director/PDMR dealings
ID	6878G

t

Company Information

AI Summary

RNS Metadata

Director/PDMR Shareholding

Company Information

AI Summary

RNS Metadata